Key Record Dates
| ClinicalTrials.gov Identifier: | NCT05643742 |
|---|---|
| Brief Title: | A Safety and Efficacy Study Evaluating CTX112 in Subjects With Relapsed or Refractory B-Cell Malignancies |
| First Submitted : | November 30, 2022 |
| First Submitted that Met QC Criteria : | November 30, 2022 |
| First Posted : | December 9, 2022 |
| Last Update Submitted that Met QC Criteria : | August 14, 2023 |
| Last Update Posted : | August 15, 2023 |